ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2213

Gene Expression Profiling of T Helper Subsets in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with Juvenile and Adult Dermatomyositis

Consuelo Lopez de Padilla1, Molly S. Hein1, Cynthia S. Crowson2, Richard S. Pendegraft3, Erik J. Peterson4, Emily Baechler5 and Ann M. Reed1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic, Rochester, MN, 3Biomedical Statistics and informatics, Rochester, MN, 4University of Minnesota, Minneapolis, MN, 5Medicine, University of Minnesota, Minneapolis, MN

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: cytokines, dermatomyositis and myositis, Genetic Biomarkers

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Muscle Biology, Myositis and Myopathies: Immunological Aspects of Inflammatory Myopathy

Session Type: Abstract Submissions (ACR)

Background/Purpose: The molecular and cellular basis for juvenile and adult dermatomyositis (JDM and ADM) presumably is similar. However, important differences in the clinical features, outcome and associated disorders suggest that different mechanisms, at least partially, may be involved. The aim of this study was to identify shared and differential molecular pathways in peripheral blood and affected muscle between JDM and ADM, and examine their association with disease activity.

Methods: Cytokine mRNA expression profiles were analyzed in paired PBMCs and muscle specimens in 7 JDM and 5 ADM. In addition, cytokine mRNA expression in blood in 21 ADM and 26 JDM subjects over 2 study visits (baseline and 6 months visit). Disease activity was also measured by IMACS core set measures and other validated tools. Expressions of type 1 helper (Th1)-related genes (IL-2, IL-12β, IFN-γ, TBX21, STAT4, TNFα, TNFSF1), Th2 (IL-4, IL-5, IL-9, IL-10, IL-13, IL-12p70, STAT6, GATA3, IRF4), Th17 (IL-1β, IL-6, IL-21, IL-23A, IL-17A , IL-17D,  IL-17F, IL-27, TGF-β1, STAT3, RORC), Tregs (FoxP3+, STAT5β), Th22 (AHR, IL-22) and Tfh (BCL6), and of innate-related genes (MIP-1α/CCL3, CCL8/MCP2, IFNα2, IFN-β and IL-8) were examined using a custom RT2 Profiler PCR Array. Wilcoxon tests, Spearman correlations and paired t-tests were used for analysis. All reported p-values were adjusted for multiple comparisons using the Bonferroni method.

Results: Expressions of cytokine mRNAs for IL-23A (p<0.001), IL-6 (p<0.001), IL-17F (p=0.022), IRF4 (p<0.001), and BCL6 (p=0.014) were significantly up-regulated in blood of JDM compared to ADM. In the muscle, however, there were no significant differences between JDM and ADM, probably due to the small sample sizes. We also compared the gene expression profiles in paired blood samples and muscle biopsies among 12 patients (7 JDM and 5 ADM). Expressions of AHR (p=0.007), IFN-γ (p=0.054), IL-23A (p=0.050), STAT5β (p=0.022), TBX21 (p=0.047), TGF-β1 (p=0.036), TNFSF1 (p=0.011), CCL3 (p=0.022) were found at higher levels in muscle compared to blood of JDM/ADM patients, the majority of these genes were Th1 and Th17 pathway-associated genes. Finally, among 16 patients with samples tested at baseline and 6 months visits, there were no significant correlations between changes in gene expression profiles in blood and disease activity measures over time.

Conclusion: We observed differences in gene expression profiling in blood between new onset JDM and ADM, many of the overexpressed genes in JDM were Th17-cytokine genes. The upregulation of Th1 and Th17-related genes was apparent in muscle compared to blood in JDM/ADM patients and may reflect activation of different Th pathways between muscle and blood.


Disclosure:

C. Lopez de Padilla,
None;

M. S. Hein,
None;

C. S. Crowson,
None;

R. S. Pendegraft,
None;

E. J. Peterson,
None;

E. Baechler,
None;

A. M. Reed,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gene-expression-profiling-of-t-helper-subsets-in-blood-and-affected-muscle-tissues-reveals-differential-activation-pathways-in-patients-with-juvenile-and-adult-dermatomyositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology